Literature DB >> 25257253

Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007.

Lisa Kobrynski1, Rachel Waltenburg Powell, Scott Bowen.   

Abstract

PURPOSE: Few studies have estimated population prevalence and morbidity of primary immunodeficiency diseases (PIDD). We used administrative healthcare databases to estimate the prevalence of PIDD diagnoses in the United States from 2001 to 2007.
METHODS: MarketScan databases compile claims from commercial health insurance plans and Medicaid, recording individual diagnoses for outpatient encounters and hospital stays. We used a cross sectional survey to estimate prevalence of PIDD using related ICD-9 codes (279.0, 279.1, 279.2, 279.8, 279.9, 288.1 and 288.2). Persons with secondary immunodeficiency diagnoses were excluded from analysis.
RESULTS: Between 2001 and 2007, prevalence of any PIDD diagnosis increased from 38.9 to 50.5 per 100,000 among privately insured and from 29.1 to 41.1 per 100,000 among publicly insured persons. B cell defects predominated. Prevalence was more than twice as high among Whites as among Blacks or Hispanics.
CONCLUSION: In this large database, we found a higher prevalence of diagnosed PIDD than has been reported previously from registries. Increased awareness may have contributed to the increasing prevalence.

Entities:  

Mesh:

Year:  2014        PMID: 25257253      PMCID: PMC4820073          DOI: 10.1007/s10875-014-0102-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  40 in total

Review 1.  Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment.

Authors:  Catherine Champi
Journal:  J Pediatr Health Care       Date:  2002 Jan-Feb       Impact factor: 1.812

2.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.

Authors:  Laurie A Myers; Dhavalkumar D Patel; Jennifer M Puck; Rebecca H Buckley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Clinical and immunologic analyses of 103 patients with common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

4.  Primary immunodeficiency diseases in Norway.

Authors:  A Stray-Pedersen; T G Abrahamsen; S S Frøland
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

5.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

6.  Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.

Authors:  Corinne Antoine; Susanna Müller; Andrew Cant; Marina Cavazzana-Calvo; Paul Veys; Jaak Vossen; Anders Fasth; Carsten Heilmann; Nicolas Wulffraat; Reinhard Seger; Stéphane Blanche; Wilhelm Friedrich; Mario Abinun; Graham Davies; Robert Bredius; Ansgar Schulz; Paul Landais; Alain Fischer
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

7.  The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

Authors:  Jerry A Winkelstein; Mary C Marino; Hans Ochs; Ramsey Fuleihan; Paul R Scholl; Raif Geha; E Richard Stiehm; Mary Ellen Conley
Journal:  Medicine (Baltimore)       Date:  2003-11       Impact factor: 1.889

8.  Identifying undiagnosed primary immunodeficiency diseases in minority subjects by using computer sorting of diagnosis codes.

Authors:  Charlotte Cunningham-Rundles; Peter Sidi; Lissette Estrella; John Doucette
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

9.  Primary immunodeficiency disorders in Sweden: cases among children, 1974-1979.

Authors:  A Fasth
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

Review 10.  Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.

Authors:  Mary Lou Lindegren; Lisa Kobrynski; Sonja A Rasmussen; Cynthia A Moore; Scott D Grosse; Marsha Lynne Vanderford; Thomas J Spira; J Steven McDougal; Robert F Vogt; W Harry Hannon; Lisa V Kalman; Bin Chen; Marifran Mattson; Timothy G Baker; Muin Khoury
Journal:  MMWR Recomm Rep       Date:  2004-01-16
View more
  37 in total

1.  Validity of Primary Immunodeficiency Disease Diagnoses in United States Medicaid Data.

Authors:  Hillary Hernandez-Trujillo; Jordan S Orange; Jason A Roy; Yanli Wang; Craig N Newcomb; Qing Liu; Sean Hennessy; Vincent Lo Re
Journal:  J Clin Immunol       Date:  2015-08-14       Impact factor: 8.317

Review 2.  Primary immunodeficiencies and their associated risk of malignancies in children: an overview.

Authors:  Samuele Renzi; Karin Petra Sabine Langenberg-Ververgaert; Nicolas Waespe; Salah Ali; Jack Bartram; Orli Michaeli; Julia Upton; Michaela Cada
Journal:  Eur J Pediatr       Date:  2020-03-11       Impact factor: 3.183

3.  Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.

Authors:  Raffaella Viti; Andrea Marcellusi; Alessandro Capone; Andrea Matucci; Alessandra Vultaggio; Claudio Pignata; Giuseppe Spadaro; Angelo Vacca; Carolina Marasco; Carlo Agostini; Francesco Saverio Mennini
Journal:  Clin Drug Investig       Date:  2018-10       Impact factor: 2.859

Review 4.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

Review 5.  Humoral Primary Immunodeficiencies in Chronic Rhinosinusitis.

Authors:  Smriti Nayan; Reza Alizadehfar; Martin Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 6.  An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity.

Authors:  Jovanka R King; Luigi D Notarangelo; Lennart Hammarström
Journal:  J Allergy Clin Immunol       Date:  2021-02       Impact factor: 10.793

7.  Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.

Authors:  Salem Al-Tamemi; Shafiq Ur Rehman Naseem; Nabila Al-Siyabi; Ibtisam El-Nour; Abdulhakim Al-Rawas; David Dennison
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

Review 8.  Primary immunodeficiency for the primary care provider.

Authors:  A W O'Keefe; M Halbrich; M Ben-Shoshan; C McCusker
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

9.  Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.

Authors:  Dimana Dimitrova; Juan Gea-Banacloche; Seth M Steinberg; Jennifer L Sadler; Stephanie N Hicks; Ellen Carroll; Jennifer S Wilder; Mark Parta; Lauren Skeffington; Thomas E Hughes; Jenny E Blau; Miranda M Broadney; Jeremy J Rose; Amy P Hsu; Rochelle Fletcher; Natalia S Nunes; Xiao-Yi Yan; William G Telford; Veena Kapoor; Jeffrey I Cohen; Alexandra F Freeman; Elizabeth Garabedian; Steven M Holland; Andrea Lisco; Harry L Malech; Luigi D Notarangelo; Irini Sereti; Nirali N Shah; Gulbu Uzel; Christa S Zerbe; Daniel H Fowler; Ronald E Gress; Christopher G Kanakry; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-04       Impact factor: 5.742

10.  Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race.

Authors:  Tyler Harkness; Xiaoqing Fu; Yuqing Zhang; Hyon K Choi; John H Stone; Kimberly G Blumenthal; Zachary S Wallace
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-27       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.